Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Psicofarma
Mexico City, Mexico City, Mexicopsicofarma.com.mx ↗
- Ownership
- Private
- Employees
- ~528
- Development stage
- Other
01
Overview
Psicofarma has the leading neuropsychiatric drug portfolio and prescription volume in Mexico, with continued double-digit growth over recent years. The company has developed both generic and proprietary medicines, including combination drugs and, more recently, oncology candidates in collaboration with academic institutions. It exports to Latin America and has FDA-approved products in clinical trials as orphan drugs, with further plans to expand into Europe and the US market.[1][2][3]
- Therapeutic areas
- OncologyNeurologyPsychiatry
- Modalities
- Small moleculeBiologicProbioticOver-the-counter product
- Industry
- Biotech
02
Partnerships
UNAM (Universidad Nacional Autónoma de México)Indian biotechnology companies (for joint venture biomanufacturing)Puerto Rico-based research partners
Beyond the preview
Go deeper on Psicofarma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Psicofarma.